You are here

News

Structural Genomics Consortium and CHDI Foundation announce open-access collaboration to discover new drug targets for Huntington’s disease

Thursday, June 5, 2014

The Structural Genomics Consortium (SGC) and CHDI Foundation have entered into a unique open-access research collaboration to discover and characterize new drug targets for Huntington’s disease (HD) using structural and chemical biology In this first partnership of its kind, SGC and CHDI have explicitly agreed not to file for patents on any of the collaborative research and to make all reagents and knowledge available without restriction to the wider research community, including pharmaceutic

Genome Alberta Program Launch - Rapid Genomics Response to PEDv

Tuesday, May 20, 2014

PEDv, an extremely infectious coronavirus that infects the small intestine of a pig, causes severe diarrhea and dehydration leading to high piglet mortality. The United States PEDv epidemic has had substantial economic impact since its May, 2013 discovery. In a single year, PEDv has spread across 30 states, killing millions of pigs and resulting in an estimated loss of 10% of the U.S. pig population.

Pages